About John Evans

Biotechnology and Health Innovation

John Evans, as CEO of Beam Therapeutics, led the announcement of groundbreaking early-stage clinical trial results in March 2025, highlighting advancements in gene editing for therapeutic applications.[1][30] This positioned him as a TIME100 Health honoree, underscoring his role in transforming health outcomes through precise, single-dose interventions.[1] His involvement extends to advisory roles, such as with AIROS Medical, where he contributes medical expertise to medical device innovations.[26]

Leadership in Education

Evans has held senior academic leadership positions, including Dean of the VinUniversity College of Business and Management in Hanoi, Vietnam, and Pro Vice Chancellor at Curtin University Dubai.[13] His focus includes corporate governance, financial control, and accounting in higher education, blending research with practical leadership to build startup business schools.[13]

Finance, Investing, and Entrepreneurship

In finance and investing, Evans demonstrates expertise in scaling businesses, exemplified by building EverLine Coatings into a $51M franchise network across North America.[12] He shares insights on people leadership, systems building, and market disruption, including U.S. expansion during the pandemic.[12] Recent stock transactions, such as selling 30,078 shares in April 2026, reflect his active role in biotech investing via Beam Therapeutics.[35]

Creator Economy and Media

Evans engages the creator economy through podcasts and interviews, discussing authentic leadership amid AI-driven changes and entrepreneurial storytelling.[12] His presence in media highlights personal journeys in business and innovation, fostering discussions on trust and scalability.[12][13]

Government, Policy, and Broader Impact

His work intersects with policy through biotech regulations enabling clinical trials and education policies supporting international campuses.[1][13] Evans advocates for frameworks that support innovation in health and education, aligning with his foundation's mission at The Evans Foundation.[bio]